January 7, 2019 01:45 PM ESTUpdated January 9, 11:59 AM

Positive ocular implant data bring Allergan one step closer to NDA; Vivek Ramaswamy spawns another 'Vant'

Natalie Grover

Reporter

→ In 2016, Brent Saunder’s Allergan $AGN orchestrated a string of deals after its $160 billion merger with Pfizer fell through thanks to Obama-era tax …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Positive ocular implant data bring Allergan one step closer to NDA; Vivek Ramaswamy spawns another 'Vant'

Natalie Grover

Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Pos­i­tive oc­u­lar im­plant da­ta bring Al­ler­gan one step clos­er to NDA; Vivek Ra­maswamy spawns an­oth­er 'Van­t'

Reporter

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Positive ocular implant data bring Allergan one step closer to NDA; Vivek Ramaswamy spawns another 'Vant'